FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.

Jun 1, 2024 - 00:00

0 4

FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.

Tags:

Previous Article

Saudi Aramco offers nearly $11.5 billion in new stock for sale

Pfizer's drug for advanced lung cancer shows promising long-term trial results

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.